Service life span extension2024-02-29T08:55:52+00:00

Services

life span extension

With in-depth knowledge of cellular senescence and mechanisms to overcome this irreversible growth arrest, Evercyte offers the development of human cell lines that can be grown without limitations while maintaining a phenotype similar to the corresponding normal cells. Besides ectopic expression of the catalytic subunit of human telomerase (hTERT) or regulators of cell cycle control pathways, Evercyte has also established protocols to reprogram cells towards induced pluripotent stem cells (iPSCs) that can give rise to theoretically any cell type of the human organism.

Related Services

characterization of primary and immortalized human cells

MSCs for production of clinical grade extracellular vesicles

all about our
EV cell factories

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

"Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed."

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

Related Product

cell factories for production of clinical grade extracellular vesicles / exosomes

Related Services

characterization of telomerized human cells

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

"Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed."

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

Go to Top